Results for tag: "Intestinal Mucosal Injury Drug"

The Intestinal Mucosal Injury Drug market is a subset of the Gastrointestinal Drugs market, which focuses on drugs used to treat diseases and disorders of the digestive system. Intestinal Mucosal Injury Drugs are used to treat conditions such as inflammatory bowel disease, ulcerative colitis, and Crohn's disease. These drugs are designed to reduce inflammation and improve the health of the intestinal mucosa. Commonly used drugs in this market include corticosteroids, immunomodulators, and biologics. Corticosteroids are used to reduce inflammation, while immunomodulators are used to suppress the immune system and reduce inflammation. Biologics are used to target specific molecules involved in the inflammatory process. Some companies in the Intestinal Mucosal Injury Drug market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda. Show Less Read more